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Summary
T cell receptor (TCR) signaling is initiated and sus-
tained in microclusters; however, it’s not known
whether signaling also occurs in the TCR-rich central
supramolecular activation cluster (cSMAC). We
showed that the cSMAC formed by fusion of micro-
clusters contained more CD45 than microclusters
and is a site enriched in lysobisphosphatidic acid,
a lipid involved in sorting ubiquitinated membrane
proteins for degradation. Calcium signaling via TCR
was blocked within 2 min by anti-MHCp treatment
and 1 min by latrunculin-A treatment. TCR-MHCp inter-
actions in the cSMAC survived these perturbations for
10 min and hence were not sufficient to sustain signal-
ing. TCR microclusters were also resistant to disrup-
tion by anti-MHCp and latrunculin-A treatments. We
propose that TCR signaling is sustained by stabilized
microclusters and is terminated in the cSMAC, a struc-
ture from which TCR are sorted for degradation. Our
studies reveal a role for F-actin in TCR signaling
beyond microcluster formation.
Introduction
Sensitive T cell activation requires the cooperation of T
cell receptors (TCRs) and adhesion molecules because
the TCRs and MHC-peptide complexes (MHCp) are
small membrane-associated proteins that interact with
low affinity and relevant MHCp are present in low abun-
dance (Shaw and Dustin, 1997; Shimizu et al., 1990;
Springer, 1990). A widely studied paradigm is based
on the utilization of lymphocyte function antigen-1
(LFA-1) on T cells and intercellular adhesion molecule-
1 (ICAM-1) on antigen-presenting cells as a major adhe-
sion and costimulation system leading to a highly
compartmentalized interface (Monks et al., 1998). This
LFA-1-based immunological synapse (IS) is composed
of a central cluster of TCR-MHCp interactions known
as the central supramolecular activation cluster
(cSMAC) surrounded by a ring of LFA-1-ICAM-1 interac-
tions known as the peripheral SMAC (pSMAC) (Bromley
*Correspondence: dustin@saturn.med.nyu.eduet al., 2001; Monks et al., 1998) and an outer fringe of
membrane enriched in CD45 known as the distal
SMAC (dSMAC) (Freiberg et al., 2002). TCR microclus-
ters have been observed early in T cell-APC interactions
that converge to form the cSMAC (Krummel et al., 2000).
Some T cell-DC IS are composed entirely of TCR micro-
clusters (Brossard et al., 2005).
The cSMAC has been proposed to represent a site of
sustained signaling based upon the central concentra-
tion of the tyrosine kinase Lck (Ehrlich et al., 2002;
Monks et al., 1998), phosphatidylinositol-3-kinase prod-
ucts (Costello et al., 2002; Huppa et al., 2003), and self-
MHCp that participate in signaling (Irvine et al., 2002;
Krogsgaard et al., 2005). The cSMAC is also a site where
TCR and CD45 interact to reset signaling, a transient
decrease in signaling needed for sustained signaling
(Freiberg et al., 2002). It has been proposed that the
cSMAC contributes to TCR degradation (Lee et al.,
2002, 2003). TCR degradation takes place via ubiquitina-
tion and targeting to multivesicular bodies that are
enriched in lysobisphosphatidic acid (LBPA) in the lyso-
somal pathway (Liu et al., 2000; Matsuo et al., 2004).
Whether the cSMAC directly participates in the process
of multivesicular body formation based on accumulation
of markers such as LBPA has not been demonstrated.
ICAM-1 and agonist MHCp complexes in a supported
planar bilayer trigger TCR clustering and are laterally
mobile such that an IS with SMACs forms and fully
activates T cells (Dustin and Colman, 2002; Grakoui
et al., 1999). In this system, the cSMAC is a site of
stable TCR-MHCp interactions (Grakoui et al., 1999).
Recently, total internal reflection fluorescence micros-
copy has been used with this system to demonstrate
continuous formation of TCR microclusters that sustain
TCR signaling (Campi et al., 2005; Yokosuka et al.,
2005). The initial size of TCR microclusters is propor-
tional to the density of agonist MHCp in the planar bi-
layer (Yokosuka et al., 2005). After the cSMAC forms,
the microclusters continue to form and are sites of
TCR signaling based on recruitment of phosphorylated
Lck, ZAP-70, and LAT and the adaptor protein SLP-76
(Campi et al., 2005; Yokosuka et al., 2005). Due to the
transport process, each peripheral microcluster lasts
only about 2 min before merging with the cSMAC.
Physically holding TCR microclusters in the periphery
augments signaling (Mossman et al., 2005). These find-
ings suggest that peripheral TCR microclusters are
important signaling structures but do not address the
signaling capability of the cSMAC.
TCR-MHCp interactions are required to sustain T cell
signaling over a period of hours to fully activate CD4+ T
cells (Beeson et al., 1996; Costello et al., 2002; Hashemi
et al., 1996; Huppa et al., 2003; Iezzi et al., 1998; Lee
et al., 2002). MHCp antibodies reduce Ca2+ to baseline
by 15 min (Huppa et al., 2003). Multivalent TCR-MHCp
interactions are relatively resistant to dissociation by
inhibitory antibodies as demonstrated by tetramer dis-
sociation (Savage and Davis, 2001). For example, I-Ek-
moth cytochrome C (MCC) 88-103 tetramers dissociate
from T cells expressing the 2B4 TCR with a half-life of
Immunity
1181 hr (Malherbe et al., 2004), while the intrinsic half-time
for binding is 36 s (Krogsgaard et al., 2003). The avidity
of TCR-MHCp interactions in microclusters and the
cSMAC are not known.
How microclusters and the cSMAC differ in composi-
tion and signaling potential are important open ques-
tions. In this report, we defined the time at which individ-
ual TCR clusters link together to form the cSMAC,
determined the relationship of CD45 to microclusters
and the cSMAC, determined whether LBPA is recruited
to microclusters or the cSMAC, determined the stability
of TCR-MHCp interactions in microclusters and the
cSMAC, and exploited differences in the lifetime of
microclusters and the cSMAC to define their roles in cal-
cium signaling. We conclude that stable TCR microclus-
ters exclude CD45 and contribute to calcium signaling.
In contrast, the cSMAC does not exclude CD45 as effec-
tively, marking its loss of signaling competence, and is
rich in LBPA, marking its potential to directly participate
in TCR elimination.
Results
TCR Microclusters Join to Form the cSMAC
Signaling is initiated and sustained in TCR microclusters
that are formed continuously in the periphery of the IS
and transported to the center to form the cSMAC (Campi
et al., 2005; Yokosuka et al., 2005). We first asked
whether the cSMAC remains a collection of independent
microclusters or if they interact in a specific manner to
form a unique integrated structure. To answer this ques-
tion, we employed TIRFM to follow TCR labeled with
Alexa-(488 or 568) H57 Fab on in vitro activated AND
TCR Transgenic (Tg) T cells interacting with supported
planar bilayers containing glycosyl-phosphatidylinositol
(GPI) anchored forms of I-Ek (GPI-I-Ek) loaded with an
agonist peptide derived from moth cytochrome C
(MCC88-103) (agonist MHCp, 10 molecules/mm2) and
GPI-ICAM-1 (300 molecules/mm2). TCR clusters formed
rapidly, as indicated by clustering of TCR labeled with
H57 Fab and direct visualization of fluorescent MHCp
in the bilayer (Figures S1A–S1C in the Supplemental
Data available with this article online) and translocated
to the center of the IS (Figures 1A–1E and Movie S1),
consistent with recent descriptions of peripheral TCR
microclusters (Campi et al., 2005; Yokosuka et al.,
2005). Initially, the microclusters moved independently
of each other, but within 5 min microclusters fuse to
form larger clusters that continue to show relative
‘‘jostling’’ movements, represented by colored areas in
Figures 1F–1I, and become immobilized in an intercon-
nected network between 5 and 15 min (Figures 1H and
1I). We defined these events, taking place between 5
and 15 min, as cSMAC formation.
Sustained TCR Microclusters Have a Narrow Range
of Sizes
We next used TIRFM to estimate the number of TCRs in
microclusters under conditions of sustained signaling
(>30 min). TCR were labeled with Alexa-568 H57 Fab
as described above. TCR clustering in microclusters
and the cSMAC was not due to membrane accumulation
of vesicles based on double staining experiments with
the membrane dye DiI and experiments with controlFab (Figures S1D–S1J). Calibration of TIRFM is chal-
lenging due to the sensitivity of the illumination to small
changes in the angle of the laser beam, but our system
was stable enough to allow collection of an entire data
set covering a range from 0 to 20 MHCp/mm2 without ad-
justment. We used the TCR signal of 25 cells adhering to
ICAM-1 containing bilayers to determine the average
fluorescence signal representing the average resting
density of TCR, which was 140 molecules/mm2 (Campi
et al., 2005), and then we used this calibration factor
for all measurements. Interestingly, the TCR distribution
was not uniform on cells adhering to GPI-ICAM-1, and
distinct clusters with an average of 6.7 TCR each were
detected (Figures S2A and S2F). This number was
consistent with recent reports of preclustering of TCR
(Schamel et al., 2005). As previously reported, the
cSMAC size was linearly related to the initial density of
agonist MHCp in the bilayer between 0.2 and 20
molecules/mm2 of GPI-I-Ek-MCC88-103 (Grakoui et al.,
1999), the range over which sustained Ca2+ signaling
was observed (Figure S2G). By 30 min, the microclusters
had decreased in size to between 11 TCR at 0.2 MHCp/
mm2 and 17 TCR at 20 MHCp/mm2 (Figures S2B,
S2C, and S2F). Thus, a more than 100-fold range of
MHCp densities the TCR microcluster size converges
to a 2-fold size range. This suggests that a minimum
size TCR microcluster may be needed to sustain
signaling.
Microclusters Exclude CD45
CD45 is excluded from sites of active TCR signaling
(Bunnell et al., 2002; Choudhuri et al., 2005), but variable
results have been obtained for CD45 in the cSMAC
(Johnson et al., 2000; Leupin et al., 2000; Sperling
et al., 1998; Zaru et al., 2002). We reinvestigated CD45
localization by TIRFM. We bound Alexa488-I3/2.3 Fab
and Alexa568-H57 Fab to AND TCR Tg T cells and im-
aged the interaction with bilayers containing 10 mole-
cules/mm2 GPI-I-Ek-MCC88-103 and GPI-ICAM-1 by
TIRFM. We found that CD45 was excluded from all early
TCR microclusters (Figures 1J–1L), which had an aver-
age diameter of 0.52 6 0.056 mm (n = 4, total of 180 mi-
croclusters measured). After cSMAC formation, CD45
was still excluded from peripheral microclusters, al-
though this was less visible in smaller clusters (Figures
1M–1O), but CD45 was included in 93% of cSMACs
(see inset, Figures 1M–1O). Quantifying fluorophore ex-
clusion from submicron diameter areas is complicated
by the spill over of signal into the exclusion zone from
surrounding fluorophores. A point spread function is
the intensity distribution measured from a point source
of light, for example a fluorescent subresolution bead,
and is a measure of the resolution of the microscope.
We used an experimental point spread function for our
TIRFM microscope to simulate the image that would
be obtained with an object having 100% exclusion of flu-
orophores from a 0.55 mm diameter region surrounded
by uniform fluorescence. The simulated image is quanti-
tatively similar to images of CD45 exclusion from similar
sized TCR microclusters at 30 s and 15 min (Figure S3).
Inclusion of TCR with CD45 in the core of the cSMAC is
consistent with FRET data in a cell-cell system showing
close proximity of TCR and CD45 in the cSMAC but not
in the periphery (Freiberg et al., 2002).
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119Figure 1. cSMAC Formation and CD45 Exclusion from Microclusters
(A–E) TCRs were visualized by TIRFM of Alexa-488-H57-Fab-labeled AND T cells forming IS on glass-supported bilayers containing ICAM-1 and
10 agonist MHCp/mm2. (B)–(E) represent TIRFM images of the box around the cSMAC in (A). The cSMAC region starts out as a collection of micro-
clusters (B), and these microclusters fuse to form the cSMAC structure. Images in (B) and (C) were scaled relative to (D) and (E) for visualization of
microclusters.
(F–I) Each image in these panels represent three sequential frames in a time course observing cSMAC formation color coded in red, green, and
blue and overlayed that are 6 s apart. Structures that appear white are those that are not undergoing motion, while portions that appear colored
are those that are undergoing substantial motion. 5–6 min after contact formation (F and G), there is more relative motion among clusters than at
10–12 min (H and I). Scale bar in (E) equals 2 mm. Similar data were obtained from at least four independent experiments.
(J–O) CD45 and TCR were visualized by TIRFM of Alexa-488-I3/2.3-Fab and Alexa-568-H57-Fab-labeled AND T cells forming IS on glass-sup-
ported bilayers containing ICAM-1 and 10 agonist MHCp/mm2. (J–L) Representative images of cells forming TCR microclusters (K) 30 s post con-
tact formation that exclude CD45. (M–O) Representative images of cells 30 min post synapse formation. Microclusters formed at 30 min (N) con-
tinue to exclude CD45 (M); however, 93% of the cSMACs (see insets) are now enriched in CD45 (three independent experiments, total n = 45
cSMACs measured). Scale bar in (L) equals 4 mm.LBPA Is Accumulated in the cSMAC, but Not
Microclusters
The cSMAC has been proposed as a site for TCR degra-
dation. LBPA is a lipid that is generated at the site of
multivesicular body formation—a process necessary
for sorting of membrane proteins for degradation (Ko-
bayashi et al., 1999; Matsuo et al., 2004; Mobius et al.,
2003). We examined the distribution of LBPA in the IS
of detergent-permeabilized cells by TIRFM immunofluo-
rescence analysis with LBPA monoclonal antibody
(Figured 2A–2L) and compared it to an isotype control
antibody (Figures 2M–2P; Kobayashi et al., 1999). There
was no specific staining for LBPA associated with T cells
adhering to planar bilayers containing ICAM-1 by TIRFM
(Figures 2I–2L) or wide-field microscopy (data not
shown). When Alexa-568 H57-labeled AND TCR Tg Tcells interacted with planar bilayers containing 2 (Fig-
ures 2A–2D) or 10 (Figures 2E–2H) GPI-I-Ek-MCC88-
103 and GPI-ICAM-1, the accumulation of LBPA in or
near the cSMAC of the fixed cells was observed in
60% of the IS. Wide-field imaging revealed that LBPA
was also present in cytoplasmic structures proximal to
the cSMAC (data not shown). No LBPA was associated
with TCR microclusters (Figure S4). The presence of
LBPA in proximity of the cSMAC is consistent with it
being a degradative compartment.
Anti-MHCp and F-Actin Depolymerization Block
Sustained Ca2+ Signaling
To understand the site for sustained signaling in the IS,
we decided to use two perturbations that are known to
acutely block ongoing Ca2+ signaling in T cells. We
Immunity
120Figure 2. Localization of LBPA in the IS
AND T cells interacting with bilayers containing the indicated amounts of agonist-MHCp were fixed at 20 min and stained for TCR and LBPA.
Enrichment of LBPA in the cSMAC is observed at 2.0 (A–D) and 10.0 agonist (E–H) MHCp/mm2. AND T cells interacting with bilayers containing
ICAM-1 did not show any staining in the TIRF field (I–L). The specificity of the antibody was determined with a isotype control antibody (M–P).
Similar results were obtained from at least three independent experiments. Scale bar equals 4 mm.used a mixture of 14-4-4 (anti-I-Ek) and D4 (anti-I-Ek in
complex with MCC88-103) (30 mg/ml each) (Reay et al.,
2000) to block TCR-MHCp interactions and latrunculin-
A to depolymerize the F-actin cytoskeleton. Although it
is well established that these treatments inhibit Ca2+ sig-
naling downstream of the TCR (Huppa et al., 2003; Vali-
tutti et al., 1995), we needed to determine the precise
time course of inhibition in order to relate the time scale
of signaling changes to the time scale of changes in
TCR-MHCp interactions in the cSMAC and microclus-
ters. We used Fura-2 ratio imaging to follow the changes
in cytoplasmic Ca2+. AND TCR Tg T cells that had inter-
acted with bilayers containing GPI-I-Ek-MCC88-103 and
GPI-ICAM-1 for 30 min were treated with the D4 and 14-
4-4 mix. D4 and 14-4-4 treatment reduced Ca2+ to base-
line within 2 min (Figures 3A and 3B), whereas latruncu-
lin-A treatment reduced Ca2+ to baseline in less than 1
min (Figures 3C and 3D). Cells that were not subject to
either treatment sustained cytoplasmic calcium over
the relevant time periods (Figure S5). By knowing the
time scales associated with signal elimination by these
perturbations, we could now interpret experiments ex-
amining the response of the cSMAC and microcluster
to the same perturbations.The cSMAC and Microclusters Resist Disruption
by Anti-MHCp
We next tested the fate of TCR-MHCp interactions
within the cSMAC and microclusters to disruption with
MHCp antibodies. We treated IS-forming AND T cells
with a mixture of 14-4-4 and D4 antibodies 20–30 min af-
ter IS formation. We evaluated the avidity of interactions
in the cSMAC by determining the number of labeled
MHCp remaining in the cSMAC and the stability of the
H57 Fab-labeled TCR remaining in the cSMAC after
anti-MHCp treatment. Over a period of 10 min after D4
and 14-4-4 treatment, the pSMAC became disorga-
nized, but 80% of MHCp (Figures 4A–4C) and TCR (Fig-
ures 4D–4F) in the cSMAC were retained. Parallel exper-
iments with fluorescent H57 IgG demonstrated
saturation staining of the cSMAC in 3 min (Figure S6).
Therefore, the failure of the anti-MHCp mixture to rapidly
reverse the cSMAC is likely due to a high probability of
rebinding of TCR to MHCp after each spontaneous dis-
sociation event. Antibodies enter theR15 nm space be-
tween the T cell and planar bilayers (Figure S6), but will
likely be excluded from the %1 nm space in the TCR-
MHCp encounter complex. Rapid rebinding of MHCp
to TCR without intervening escape of MHCp from the
Stable TCR Microclusters Signal
121Figure 3. MHCp Antibodies and Latrunculin-A Inhibit Sustained Calcium Signaling in T Cells Forming IS
AND TCR Tg T cells were labeled with Fura-2-AM and were incubated with supported planar bilayers containing ICAM-1 and 10 agonist MHCp/
mm2. 25 min after IS formation, the 340/380 ratio was determined by wide-field fluorescence microscopy every 5 s. The low and high calcium
ratios corresponding to cells in EGTA Mg2+ (+) Ca2+ (2) buffer and ionomycin were also determined. Injections of anti-MHCp (A and B) or latrun-
culin-A (C and D) are indicated as dark gray bar in graphs. Individual cell values (A and C) and population averages (B and D) show that cyto-
plasmic Ca2+ concentration reduced in 2 min after anti-MHCp treatment and 1 min after latrunculin-A treatment. The blue line in each graph rep-
resents calcium concentration of cells treated with EGTA Mg2+ (+) Ca2+ (2) buffer. Error bars in (B) and (D) represent standard deviation. Similar
results were obtained from two independent experiments.encounter complex is a form of ‘‘avidity’’ leading to sta-
bility of the TCR microclusters. After D4 and 14-4-4
treatment, the peripheral microclusters completed their
transit to the cSMAC over a period of 2 min (Figures 4G–
4J), but no new microclusters formed (Figures 4I and 4J).
Movie S2 shows the effect of MHCp antibodies on the
dynamics of H57 Fab-labeled TCR. The formation of
new TCR microclusters was unaffected by a control
mouse IgG. Thus, microclusters and cSMACs displayed
high stability in the presence of MHCp antibodies. These
results suggest that calcium signaling is not sustained
by interactions in the cSMAC but require the continuous
formation of TCR microclusters in the periphery.
Anti-MHCp Inhibition of New Microclusters Stops
Zap-70 Recruitment
The recruitment of Zap-70-GFP to TCR microclusters
correlates with sustained signaling (Yokosuka et al.,
2005). Zap-70-GFP was introduced into AND TCR Tg T
cells by retroviral transduction, and the cells were al-
lowed to form IS on bilayers containing agonist MHCp
and ICAM-1. After 30 min, the movement of Zap-70-
GFP-positive clusters from the pSMAC to the cSMAC
was evaluated by confocal microscopy before and after
addition of D4 and 14-4-4 antibody mix. As previouslydescribed, Zap-70-GFP accumulated in discrete clus-
ters that translocated at w2 mm/min and fade as they
reach the cSMAC (Figures 4K and 4L, Movie S3; Yoko-
suka et al., 2005). After D4 and 14-4-4 treatment, the al-
ready formed Zap-70-GFP clusters continued to move
to the cSMAC and fade as they reached the cSMAC (Fig-
ures 4M and 4N, Movie S3). D4 and 14-4-4 treatment
immediately eliminated formation of new Zap-70-GFP
microclusters. The time required for microclusters to
reach the cSMAC corresponds closely with the time re-
quired to extinguish signaling after D4 and 14-4-4 treat-
ment. Zap-70-GFP associated with the cSMAC did not
change after D4 and 14-4-4 treatment. This suggests
that cSMAC-associated Zap-70 was nonfunctional in
signaling for Ca2+ elevation.
The cSMAC Is F-Actin Independent
TCR microcluster formation by AND TCR Tg T cells on
bilayers with agonist MHCp and ICAM-1 is dependent
upon F-actin (Campi et al., 2005). In order to under-
stand how F-actin contributes to the maintenance of
microclusters, we tested the effect of latrunculin-A on
IS undergoing sustained signaling at 30 min. We mea-
sured cSMAC avidity by quantifying the number of fluo-
rescent MHCp complexes retained in the cSMAC
Immunity
122Figure 4. MHCp Antibody Treatment Does Not Disrupt the cSMAC or Microclusters, but Prevents New Microcluster Formation
Images of AND T cell forming an IS on bilayers containing ICAM-1 and 10 agonist MHCp/mm2 before (A, D) and after (B, E) treating cells with MHCp
antibodies (red; Cy5-Icam-1, green; Oregon Green I-EK in [A] and [B] and Alexa-488-H57-Fab in [D] and [E]). Scale bar equals 4 mm. TCR-MHCp
interactions in the cSMAC are at 80% of initial levels at 10 min after addition of anti-MHCp antibodies based on retention of I-Ek fluorescence (C)
and TCR fluorescence (F). A line connects data points for each cell before and after treatment. Some cells have no reduction in TCR-MHCp in-
teraction, yet all cells show reduced Ca2+. Microclusters continue to form up to 30–60 min in the mature IS (G, H). Treatment with anti-MHCp
blocked formation of new microclusters; however, the existing microclusters were chased into the cSMAC (I, J). Zap-70-GFP was introduced
into AND T cells via retroviral transduction. Confocal imaging was performed on these cells interacting with bilayers containing ICAM-1 and
10 agonist MHCp/mm2. Microclusters recruit Zap-70 and fade as they approach the cSMAC (K, L). Treatment with anti-MHCp blocked the recruit-
ment of Zap-70 to the microclusters, and the existing ones were chased into the cSMAC by 1–2 min. Tracks shown start in frames (G), (I), (K), and
(M) and end in frames (H), (J), (L), and (N). Similar results were obtained from three independent experiments. Scale bar equals 4 mm.(Figures 5A–5C), and we measured TCR stability by
quantifying the relative TCR fluorescence associated
with the cSMAC (Figures 5D–5F). Latrunculin-A treat-
ment caused disorganization of the pSMAC (Figures
5B and 5E, red), but only small changes in the cSMAC(Figures 5B and 5E, green). The cSMACs were resistant
to disruption by latrunculin-A based on retention of
80% of MHCp and TCR signals in the cSMAC at 10
min after treatment (Figures 5C and 5F). We next exam-
ined the effect of latrunculin-A on microclusters by
Stable TCR Microclusters Signal
123Figure 5. F-Actin Depolymerization Arrests Microclusters but Does Not Disrupt Microclusters or the cSMAC
Images of AND T cell forming an IS on bilayers containing ICAM-1 and 10 agonist MHCp/mm2 before (A, D) and after (B, E) treating cells with
latrunculin-A (red; Cy5-Icam-1, green; Oregon Green I-Ek in [A] and [B] and Alexa-488-H57-Fab in [D] and [E]). Scale bar equals 4 mm. TCR-
MHCp interactions in the cSMAC are at 80% of initial levels at 10 min after addition of latrunculin-A based on retention of I-Ek fluorescence
(C) and TCR fluorescence (F). A line connects data points for each cell before and after treatment. The translocation of microclusters toward
the cSMAC in the mature IS was imaged with TIRFM and tracked at 30 min (G–J). Latrunculin-A prevented the formation of new microclusters
and many microclusters in the periphery were dispersed, while some near the cSMAC persisted and their translocation was blocked. Similar
results were obtained from two independent experiments. Scale bar equals 4 mm.TIRFM (Figures 5G–5J and Movie S4). Microclusters
stopped translocating immediately after latrunculin-A
treatment. Many of the arrested microclusters per-
sisted for many minutes, particularly those closer to
the cSMAC. As expected, no new microclusters formed
after latrunculin-A treatment (Movie S4). Thus, the sta-
bility of the cSMAC does not depend on actin.
TCR Microclusters Are High-Stability Structures
The result that microclusters have a high stability inde-
pendent of F-actin has important implications for T cell
sensitivity, so we wanted to determine if this property
was manifested before cSMAC formation. We added
D4 and 14-4-4 to T cells that were undergoing theexpansion phase of IS formation and had just formed
an array of TCR microclusters after 30 s. Treatment
with D4 and 14-4-4 at this stage arrested TCR micro-
clusters without cSMAC formation (Movie S5). The
microclusters were stable for w6 min (Figures 6A–6E),
after which the cells began to migrate and shed the
TCR clusters. The stability of TCR microclusters was
F-actin independent, as shown by the observation that
treatment with latrunculin-A at 30 s arrested newly
formed microclusters but did not disrupt the TCR clus-
ters for at least 5 min (Figures 6F–6J, Movie S6). Latrun-
culin-A eliminates F-actin from previously actin-positive
peripheral microclusters within 1 min, the time frame for
loss of Ca2+ signaling (Figure S7). Thus, microcluster
Immunity
124Figure 6. Microclusters Are High-Avidity Structures Based on Resistance to Anti-MHCp and Latrunculin-A
TCRs were visualized by TIRFM of Alexa-488-H57-Fab-labeled AND T cells forming IS on glass-supported bilayers containing ICAM-1 and 10
agonist MHCp/mm2. Cells were treated with anti-MHCp (A–E) or latrunculin-A (F–J) when they formed an immature synapse or were in the expan-
sion phase. Anti-MHCp was added between (B) and (C) and latrunculin-A was added between (G) and (H). Microclusters showed resistance to
both these treatments, as shown in (C)–(E) and (H)–(J). Similar results were obtained from two independent experiments. Scale bar equals 4 mm.formation is F-actin dependent as previously shown
(Campi et al., 2005), but the microclusters rapidly be-
come F-actin independent for stability but not signaling.
Discussion
Our data supports a model in which there are three dis-
tinct types of TCR clusters in the IS. On a nonadherent
cell surface, we assume that TCR and LFA-1 are uni-
formly distributed. Upon adhesion, we have observed
formation of small TCR clusters. We would speculate
that integrin-mediated remodeling of the cortical actin
cytoskeleton is responsible for this antigen-indepen-
dent TCR clustering. Although we provide no evidence
that these clusters function to enhance formation of sig-
naling microclusters, support for this hypothesis has
been shown (Schamel et al., 2005). Upon engagement
by MHCp, F-actin-dependent TCR microclusters with
a high stability are formed. These microclusters exclude
CD45 and signal as they translocate through the dSMAC
and pSMAC, but they can also signal when arrested by
barriers to MHCp transport (Mossman et al., 2005).
When these clusters reach the cSMAC, they undergo
a dramatic change in that CD45 becomes intermixed
with TCR again, signaling stops, and LBPA accumulates
in the cSMAC. The presence of LBPA in the cSMAC sug-
gests that the cSMAC sorts TCR into multivesicular bod-
ies for degradation. A higher level of membrane dye fluo-
rescence in the cSMAC region is consistent with
irregular membrane topology in the cSMAC or with cyto-
plasmic vesicular structures in the TIRFM field, both of
which could carry CD45 without size-based exclusion.
We demonstrate that F-actin is important both for mi-
crocluster formation as previously shown (Campi et al.,
2005) and also for translocation and signaling.
MHCp levels on APCs regulate cSMAC size and the
extent of TCR downregulation and thus free TCR levels.
Regardless of the amount of MHCp encountered by
T cells on APCs, signaling is sustained via formation of
microclusters 11–17 TCRs in size. Thymocytes, which
are w10-fold more sensitive than T cells, do not form
translocating TCR microclusters, and this absence ofdownregulation may result in more signal per agonist
MHCp and greater sensitivity (Hailman et al., 2002).
In this microcluster-based model, high sensitivity to
antigen can be achieved in one of at least two ways. Da-
vis and colleagues have demonstrated that dimers of
agonist MHCp paired with a self-MHCp can activate T
cells outside of an IS (Krogsgaard et al., 2005). Self-
MHCp also synergize with agonist MHCp in bilayer sys-
tem experiments (Wu¨lfing et al., 2002). However, when
we dilute agonist MHCp to a few molecules per contact
area with no addition of self-MHCp, we still get highly
sensitive T cell activation (data not shown). This sug-
gests that strong agonists like I-Ek-MCC88-103 for
AND TCR nucleate TCR microclusters without dimer for-
mation. Mechanisms by which single membrane bound
ligands could trigger signaling have been proposed that
involve CD45 (Choudhuri et al., 2005). CD45 is a pivotal
phosphatase in TCR signaling that has an essential
role in priming of Lck for activation (Koretzky et al.,
1990), but can also act as a negative regulator of TCR
signaling (D’Oro and Ashwell, 1999; Mustelin et al.,
1995). The kinetic segregation model states that CD45
exclusion from sites of TCR engagement with agonist
MHCp is a primary event in initiation of signaling and
could allow a single TCR-MHCp interaction of sufficient
kinetic stability to initiate TCR signaling (Choudhuri
et al., 2005). We demonstrate here that microclusters
formed by agonist MHCp engagement exclude CD45.
This submicron exclusion zone may allow increased
phosphorylation by tyrosine kinases in the cluster, in-
cluding CD45-primed Lck that diffuses into the clusters
from surrounding CD45-rich domains as recently dem-
onstrated by single molecule imaging (Douglass and
Vale, 2005). The subsequent colocalization of CD45
with the TCR in the cSMAC may contribute to inactiva-
tion of the kinase cascade as previously suggested
(Freiberg et al., 2002). The mechanisms by which CD45
can be excluded from one site of TCR engagement,
the microclusters, and accumulated in another, the
cSMAC, is not known, but CD45 location appears to
be controlled by both steric exclusion and lateral inter-
actions (Choudhuri et al., 2005; Irles et al., 2003).
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ters associated with signaling were performed with
Fc3RI engaged by multivalent ligands (Stauffer and
Meyer, 1997; Wilson et al., 2000, 2001). Small Fc3RI
receptor clusters on mast cells are more efficient in sig-
naling than larger clusters (Metzger et al., 1999), fore-
shadowing our finding that the large cSMAC is not
a signaling structure. Fc3RI and LAT clusters appear to
undergo actin-dependent rearrangements on a relatively
short length scale that leads to receptor endocytosis
and termination of signaling (Wilson et al., 2000). Per-
haps similar short-range mechanisms are invoked in
regulation of TCR signaling in the case of anti-CD3-
coated substrates in which cSMACs cannot form, yet
T cells are effectively activated (Bunnell et al., 2001,
2002).
cSMAC formation is not required for T cell signaling
(Lee et al., 2002, 2003). We now show that TCR-MHCp
interactions in the cSMAC are not sufficient to sustain
Ca2+ signaling. We have demonstrated this with an inter-
vention that blocks formation of new microclusters while
leaving the cSMAC intact. However, our finding that
LBPA is specifically accumulated in the cSMAC directly
supports the hypothesis that the cSMAC is involved in
sorting of ubiquitinated TCR complexes for degradation
as first proposed by Lee et al. (2002). We could not dis-
tinguish whether LBPA was recruited to the plasma
membrane of the cSMAC and nearby endomembrane
compartments versus only nearby endomembrane
compartments by means of the standard LBPA staining
conditions with detergent permeabilization. However,
there are precedents for recruitment of the ESCRT com-
plex to the plasma membrane (Lin et al., 2005). The
mechanism by which Zap-70 is sometimes stably re-
cruited to the cSMAC without evidence of function is
not clear. Samelson and colleagues reported that initial
recruitment of Zap-70-GFP to TCR clusters induced by
anti-CD3 antibodies is dynamic but then evolves into
a more stable interaction (Bunnell et al., 2002). However,
there is no way to determine whether these dynamic and
stable forms of Zap-70 function differently in the solid
phase anti-CD3 system. One explanation for stably as-
sociated Zap-70 could be trapping in multivesicular
body vesicles associated with the LBPA-positive
cSMAC.
We conclude that the cSMAC is not involved in sus-
tained Ca2+ signaling, but our observations on micro-
clusters suggest that these structures rapidly acquire
the chemical stability of the cSMAC, such that concepts
originally applied to interactions in the cSMAC may be
useful in understanding kinetics of interaction in micro-
clusters (Lee et al., 2003).
Experimental Procedures
Materials
H57 (anti-TCRb) and 14-4-4 (anti-I-Ek) hybridomas were obtained
from ATCC, and D4 (anti-IEk in complex with MCC) was a generous
gift of M. Davis. Anti-CD45 I3/2.3 was obtained from T. Woodford-
Thomas (Donald Danforth Plant Science Center, St. Louis, MO)
(Trowbridge, 1978). Anti-lyso-bis-phosphatidic-acid (6C4) hybrid-
oma supernatant was obtained from J. Gruenberg (University of Ge-
neva) (Kobayashi et al., 1999). Biotinylated mouse isotype control
was purchased from BD, Pharmingen. Latrunculin-A was purchased
from Sigma. Agonist peptide MCC88-103 was from the Dana FarberCancer Institute, Molecular Biology Core (Boston, MA). Alexa-fluor
and other dyes were from Molecular Probes. Fab fragments were
prepared by Papain digestion, purified by ion-exchange, and veri-
fied by SDS-PAGE. Fluorescent labeling of antibodies and Fab frag-
ments was performed according to manufacturer’s instructions.
Mice and Cell Culture
AND TCR transgenic mice were purchased from Jackson Laborato-
ries (Bar Harbor, ME) and were crossed to B10.Br mice. All experi-
ments were performed on F1 progenies between 8 and 12 weeks
of age. AND T cells were activated in vitro as described (Campi
et al., 2005). All mice were housed in specific pathogen-free condi-
tions and cared for in accordance with protocol approved by Institu-
tional and Animal Care and Use Committee.
Bilayers
Glass-supported DOPC bilayers incorporating GPI-anchored forms
of I-Ek and ICAM-1 were prepared in flow cells (Bioptechs, Butler,
PA) as described before (Grakoui et al., 1999). The bilayers were
loaded with 50 mM MCC88-103 peptide in citrate buffer (pH 4.5) for
24 hr. The peptide loading efficiency was determined as described
before and was 20%–30%. The type of fluorescent tagging of the
proteins incorporated in the bilayer for different experiments are in-
dicated in the figure legends. Unless otherwise specified, all the den-
sity of the proteins in the bilayers was: I-Ek 1-100 sites/mm2 and
ICAM-1 300 sites/mm2.
Anti-LBPA Staining
Anti-LBPA staining was performed essentially as described
(Kobayashi et al., 1999). AND T cells were made to interact with an-
tigen-specific bilayers and after 30 min were fixed with 2% parafor-
maldehyde for 20 min. The cells were then incubated in media con-
taining 50 mM NH4Cl for 10 min. The cells were then blocked with
0.1% BSA for 20 min and then stained with the primary antibody
(6C4) or isotype control for 30 min. The staining buffer contained
0.05% Saponin. This was followed by staining with a secondary
antibody (anti-mouse IgG Fab2).
Calcium Measurements
Intracellular calcium concentrations were measured by Fura-2 ratio.
AND T cells were labeled with 2 mM of Fura-2 in serum-free media
for 30 min at room temperature. The dye was washed with serum-
containing media and further incubated at 37ºC for 30 min in se-
rum-containing media. The cells were immediately used for experi-
mentation after that. Images were acquired through a 403 NA 1.3
NeoFluar objective. The ratio of emission at 510 nm excited at 340
nm and 380 nm was determined with appropriate background sub-
tractions. At the end of each experiment, high Ca2+ (1 mM ionomycin
+ 2 mM Ca2+ in media) and low Ca2+ (1 mM ionomycin + 0 mM Ca2+, 2
mM EGTA in the media) were determined.
Microscopy
All microscopy was performed on an Olympus inverted IX-70 micro-
scope equipped with a Xenon-arc lamp as light source, Ludl shutter
and filter wheels equipped with appropriate excitation and emission
filters, Ludl XY motorized state, piezo-electric stage for z movement
of objective, Hamamatsu 12-bit ORCA-ER cooled CCD, Olympus
TIRF module, and 2W Kr-Ar laser (Spectra Physics) launched in a sin-
gle mode fiber (Oz Optics) via an AOTF (Solamere Technologies).
The 603 1.45 N.A. TIRF objective from Olympus was used for all ex-
periments except for Fura-2 ratio imaging. The hardware on the
microscope was controlled by IPLAB software on a Powermac G4
Macintosh computer.
TIRF Imaging of TCR
TIRF illumination was aligned according to manufacturer’s instruc-
tions and was verified by making sure that fluorescence could be col-
lected only from the bilayer plane. Reference particles that were
more than 0.2 mm above the bilayer were not detected. Exposure
times of 1–2 s were used to acquire images with 0.1 or 0.2 mm per
pixel by the 603 1.45 N.A. objective. For tracking purposes, images
were collected at an interval of 6 s. Labeled anti-TCR Fab was pres-
ent at 10 mg/ml throughout the experiment. Alexa488-conjugated
Immunity
126anti-human CD2 Fab at 10 mg/ml was used a control (Figure S1). We
could not detect any signal from this Fab in the IS.
ZAP-70-GFP Transduction and Confocal Microscopy
AND T cells were transduced with ZAP-70-GFP and confocal mi-
croscopy was performed as described (Yokosuka et al., 2005).
Image and Data Analysis
Data was analyzed with the Metamorph, IPLab (Scanalytics, Vienna,
VA) and ImageJ Software. For calibration of TIRFM images, the av-
erage number of TCR on AND T cell blasts measured with H57 Ab
is 42,000 per cell or 140 molecules/mm2 (Campi et al., 2005), which
we assume to be the average TCR density for the population of all
T cells adhering to ICAM-1 containing bilayers. We then measured
the average fluorescence intensity (U/mm2) for at least 25 T cells ad-
hering to ICAM-1 bilayers and divided this by 140 to obtain the cal-
ibration value (U/molecule). The cSMAC and clusters (area > 0.16
mm2) were measured and local background was subtracted based
on area of 5–10 pixels near the structure that did not include
a TCR cluster. We assume that free TCR diffuse in and around the
engaged receptors in the cSMAC and peripheral TCR clusters.
Then, the integrated fluorescence units in relevant area are divided
by the U/molecule calibration value to determine the number of
TCR in the structure. The results were internally consistent in that
at 20 agonist MHCp/mm2, 95% of the TCR were recruited to the
cSMAC region at 30 min and the range of values in the TIRFM field
with this calibration factor was near 40,000 at this antigen dose.
Therefore, the average values for the cSMAC were consistent with
other observations and the peripheral TCR clusters were measured
with the same calibration value. One caveat of this estimate is that
the TIRFM illumination field is not flat, so variation across the field
will lead to errors in the determination of the number of TCR in indi-
vidual clusters. Therefore, some of the spread in the data points may
be due to local variation in illumination, but enough points were mea-
sured in different experiments to obtain similar mean values be-
tween experiments.
Supplemental Data
Supplemental Data include seven figures and six movies and can be
found with this article online at http://www.immunity.com/cgi/
content/full/25/1/117/DC1/.
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